Crispr Therapeutics Ag (CRSP)
$121.02
2.02 (1.70%)
CRSP Stock Quote Delayed 30 Minutes
CRSP Stock: The Good News Goosing CRISPR Therapeutics Shares Today
Shares of CRSP stock are rising on Friday after CRISPR Therapeutics provided a positive business update regarding its leading drug candidate.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
9.22B
PE Ratio
-17.46
EPS
-6.93
Volume (Avg. Vol.)
1.43M
Day's Range
119.35 - 125.31
52-Week Range
76.71 - 220.20
Dividend & Yield
N/A (N/A)
CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News
Can CRISPR Therapeutics Stock Investors Steer Clear of Ethical Concerns?
While the technologies that undergird CRSP stock is nothing short of mind-blowing, you should be aware of the ethical risks.
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century
Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy.
Gene Editing Stocks: Why EDIT, CRSP, NTLA Stocks Continue to Soar
Today, gene editing stocks are soaring amid increasingly bullish sentiment in this sector following strong results from Intellia.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
So what will the stock market do today? All eyes are on gene-editing stocks like NTLA and on recovering crypto prices.
Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks
Gene editing stocks are getting a boost on Monday morning after Intellia Therapeutics said it was successful using CRISPR gene-editing therapy directed inside the body to an internal organ.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Good morning! Let's get ready for trading to start off strong this week with a look at the biggest pre-market stock movers for Monday!
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? Dogecoin prices and other cryptocurrencies stole the show, and CRISPR stocks sold off.
CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today
A "sell" rating is one thing, but a price target barely half of the Thursday close? It's no wonder Editas stock is crashing, and taking other gene-editing stocks with it.
Investing in CRISPR Stocks: Ultimate Genetic Editing Guide
The biotech space is on the verge of hypergrowth, thanks to a scientific breakthrough in genetic editing. This is your ultimate guide to understanding and profiting from CRISPR stocks.
CRISPR Therapeutics Stock Looks Like a Long-Term Biotech Winner
Gene editing has the potential to revolutionize medicine. With CRISPR Therapeutics leading the way, CRSP stock should benefit.
CRISPR Therapeutics Is a Falling Knife You Don’t Want to Catch
With possibly the worst of the novel coronavirus pandemic over, on the surface CRSP stock seems to be a worthwhile rebound pick. However, the technical outlook suggests otherwise.
Gene Editing Stocks: What BLUE, NTLA, BEAM, CRSP and EDIT Are Doing Today
Gene editing stocks are on the move Wednesday with investors taking extra interest in biotech companies on news from two major players.
Cathie Wood Stocks: The Winners and Losers in ARKK ETF Today
Cathie Wood continues to do well in stocks as ARK Innovation ETF (ARKK) gains on Tuesday alongside the company's major holdings.
Why CRSP Stock Is a Less Dicey Risk Asset Today
Crispr Therapeutics offers one of the next big technologies and today shares of CRSP stock afford investors access to growth at a discount.
7 CRISPR Stocks for the Future of Medicine
Between these seven genetic editing pioneers, you have the widest exposure to the biggest scientific breakthrough of the century.
CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today
CRSP stock is rallying today as CRISPR Therapeutics and its gene-editing peers move into the spotlight. Here's what you should know.
